List of articles with "oncology"

Myosin at Biocom 2026

Myosin at Biocom 2026

United States oncology La Jolla Myosin Therapeutics MT-125
DUB Inhibitors Market Growth

DUB Inhibitors Market Growth

None oncology Therapeutics DUB inhibitors
Servier's Strong Performance

Servier's Strong Performance

France oncology pharmaceuticals Servier Suresnes
Servier's Growth Prospects

Servier's Growth Prospects

France oncology Neurology Servier Suresnes
Servier's Growth Outlook

Servier's Growth Outlook

France oncology pharmaceuticals Servier Suresnes
Brazil's Cancer Immunotherapy Breakthrough

Brazil's Cancer Immunotherapy Breakthrough

Brazil São Paulo oncology Biosimilars Blau Farmacêutica
Mabwell's 7MW4911 Trial

Mabwell's 7MW4911 Trial

China Shanghai oncology Mabwell 7MW4911
Daiichi Sankyo Toronto HQ

Daiichi Sankyo Toronto HQ

Canada Daiichi Sankyo Toronto oncology Toronto HQ
Precision Platforms in Cancer

Precision Platforms in Cancer

None oncology Precision Medicine GT Biopharma
Hoth's HT-001 Trial Milestone

Hoth's HT-001 Trial Milestone

United States New York oncology Hoth Therapeutics HT-001
AI Drug Discovery Collaboration

AI Drug Discovery Collaboration

France oncology Pierre Fabre Iktos Castres
AI Cancer Drug Discovery

AI Cancer Drug Discovery

France oncology Pierre Fabre Iktos Castres
Perceptive Discovery Expands

Perceptive Discovery Expands

United States Boston oncology Perceptive Discovery Radiochemistry
Genomic Biomarkers Market

Genomic Biomarkers Market

USA oncology Delray Beach Next-generation Sequencing Genomic Biomarkers
Verana Health and COTA Merger

Verana Health and COTA Merger

USA San Francisco oncology COTA Verana Health
REV Clinical Unveiled

REV Clinical Unveiled

United States oncology Bakersfield Neurology REV Clinical
Transforming Community Oncology

Transforming Community Oncology

USA oncology Frisco, Texas MiBA AllyGPO
Innovative Care in Pasco

Innovative Care in Pasco

USA oncology Florida Cancer Specialists Hudson H. Bindu Lingam
Amgen Acquires Dark Blue

Amgen Acquires Dark Blue

United States oncology Amgen Thousand Oaks Dark Blue Therapeutics
NanOlogy Appoints Dr. Goldberg

NanOlogy Appoints Dr. Goldberg

United States Fort Worth oncology NanOlogy John M. Goldberg
IDEAYA at J.P. Morgan

IDEAYA at J.P. Morgan

United States San Francisco oncology J.P. Morgan IDEAYA Biosciences
Insilico and Servier Partnership

Insilico and Servier Partnership

USA Cambridge oncology Insilico Medicine Servier
First Patient Dosed

First Patient Dosed

USA Dulles oncology FAPI-74 SOFIE Biosciences
Kazia Regains Nasdaq Compliance

Kazia Regains Nasdaq Compliance

oncology Australia Sydney Kazia Therapeutics Nasdaq Compliance
Tinengotinib Approved

Tinengotinib Approved

China Nanjing oncology TransThera tinengotinib
Dr. Elliot Abbey Recognized

Dr. Elliot Abbey Recognized

USA oncology Hematology Chesterfield Dr. Elliot Abbey
Lee Campbell Drinkard Honored

Lee Campbell Drinkard Honored

United States oncology Irving Pinnacle Lifetime Member Lee Campbell Drinkard
AI Partnership for Oncology

AI Partnership for Oncology

United States Utah oncology Canopy Utah Cancer Specialists
AllinkBio Secures $47M

AllinkBio Secures $47M

Shanghai USA oncology Allink Biotherapeutics ADCs
Allink Biotherapeutics Funding

Allink Biotherapeutics Funding

Shanghai USA oncology Allink Biotherapeutics ADCs
Lunit & Daiichi Sankyo AI Partnership

Lunit & Daiichi Sankyo AI Partnership

South Korea Seoul Daiichi Sankyo oncology Lunit
Surge in Precision Cancer Treatments

Surge in Precision Cancer Treatments

None oncology Immunotherapy GT Biopharma
Gerosynth Labs INAD Approvals

Gerosynth Labs INAD Approvals

USA oncology Bloomington Animal Health Gerosynth Labs
ZeuReka & UBE Partnership

ZeuReka & UBE Partnership

Japan oncology Tokyo UBE Zeureka
Nuvalent Welcomes Ron Squarer

Nuvalent Welcomes Ron Squarer

USA Cambridge oncology Nuvalent Ron Squarer
Indivumed and URMC Partnership

Indivumed and URMC Partnership

USA oncology Rochester URMC Indivumed
Indivumed & URMC Team Up

Indivumed & URMC Team Up

USA oncology Rochester Indivumed Wilmot Cancer Institute
Dr. Townson Joins Expression

Dr. Townson Joins Expression

United States Atlanta oncology Expression Therapeutics Dr. David Townson
Canopy RTM Impact

Canopy RTM Impact

USA Orlando oncology Canopy RTM Platform
O'Connor Joins Jubilant

O'Connor Joins Jubilant

United States oncology Yardley Jubilant Therapeutics Daniel O'Connor
Renuka Iyer Named CMO

Renuka Iyer Named CMO

USA oncology Plymouth Meeting NCCN Renuka Iyer
Dr. Iyer Joins NCCN

Dr. Iyer Joins NCCN

USA oncology Plymouth Meeting NCCN Renuka Iyer
Emerald's New VP of Oncology

Emerald's New VP of Oncology

Singapore oncology Emerald Clinical Luke Gill
Karyopharm Inducement Grants

Karyopharm Inducement Grants

USA oncology XPOVIO Newton Karyopharm Therapeutics
Margaret Dugan Joins Whitehawk

Margaret Dugan Joins Whitehawk

United States oncology Morristown Whitehawk Therapeutics Margaret Dugan
Rhabdomyosarcoma Market Growth

Rhabdomyosarcoma Market Growth

USA Las Vegas oncology DelveInsight Rhabdomyosarcoma
IDEAYA Investor Events

IDEAYA Investor Events

USA oncology IDEAYA Biosciences South San Francisco Precision Medicine
New Oncology Fellows Announced

New Oncology Fellows Announced

USA oncology Caris Life Sciences Irving Precision Medicine
Canopy's Platform Impact

Canopy's Platform Impact

USA oncology Orlando, Florida Canopy ASH2025
Galmed's Cancer Treatment

Galmed's Cancer Treatment

Israel oncology Ramat Gan Galmed Pharmaceuticals Aramchol

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.